Department of Pediatrics, Korea University College of Medicine, Seoul, Korea.
Department of Medical Statistics, The Catholic University of Korea, Seoul, Korea.
J Korean Med Sci. 2018 May 14;33(25):e174. doi: 10.3346/jkms.2018.33.e174. eCollection 2018 Jun 18.
Henoch-Schӧnlein purpura (HSP) is a common vasculitis of childhood. Though HSP is usually self-limiting, severe complications can occur. The management for this condition has not been established yet. Thus, this nationwide study aimed at investigating epidemiological characteristics of children with HSP in Korea. The patterns of clinical practice with regard to the complications of the condition were also investigated.
This is a national population-based study that used the National Health Insurance Database. Children below 18 years who were diagnosed with HSP in Korea between 2006 and 2015 were enrolled. Data, such as age, sex, yearly and monthly distribution of HSP, hospitalization, re-hospitalization, comorbidities, and interventions were obtained. The use of steroids was also analyzed.
A total of 56,841 children were enrolled. The annual incidence of HSP was 55.9 per 100,000 children. The peak age was 5 years. Spring was the most prevalent season. Sex (male) and young age (< 9 years) were risk factors of hospitalization. Younger children were more likely to be re-hospitalized and suspected with intussusception, arthritis, and nephritis. Only 4 children received laparotomy. In total, 57% were managed with steroids, and mean durations of medication were 4-5 days. Children who were hospitalized and those with comorbidities used steroids more frequently ( < 0.001).
The annual incidence of HSP is 55.9 per 100,000 children which is higher in Korea than that in other countries. Younger children can have a more severe clinical course. This nationwide survey provides valuable information to understand HSP in children and to inspire further research on HSP.
过敏性紫癜(HSP)是儿童常见的血管炎。虽然 HSP 通常是自限性的,但可能会发生严重的并发症。目前尚未确定该疾病的治疗方法。因此,本项全国性研究旨在调查韩国儿童 HSP 的流行病学特征,并探讨该疾病并发症的临床治疗模式。
这是一项全国性的基于人群的研究,使用了国家健康保险数据库。2006 年至 2015 年间,韩国被诊断为 HSP 的 18 岁以下儿童被纳入研究。收集的数据包括年龄、性别、HSP 的年度和月度分布、住院、再次住院、合并症和干预措施等。同时还分析了类固醇的使用情况。
共纳入 56841 名儿童。HSP 的年发病率为 55.9/10 万儿童。发病高峰年龄为 5 岁,高发季节为春季。性别(男性)和年龄较小(<9 岁)是住院的危险因素。年龄较小的儿童更有可能再次住院,且更容易出现肠套叠、关节炎和肾炎。仅 4 名儿童接受了剖腹手术。总体而言,57%的患儿接受了类固醇治疗,平均用药时间为 4-5 天。住院患儿和合并症患儿更频繁地使用类固醇(<0.001)。
HSP 的年发病率为 55.9/10 万儿童,高于其他国家。年龄较小的儿童可能会出现更严重的临床病程。本项全国性调查提供了有价值的信息,有助于了解儿童 HSP,并激发对 HSP 的进一步研究。